BVT Aktienanleihe NKE 27.09.2024/ DE000VM5CBX3 /
24/05/2024 20:04:40 | Var.+0.320 | Denaro10:06:39 | Lettera10:06:39 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
94.740EUR | +0.34% | 94.970 Quantità in denaro: 50,000 |
95.280 Quantità in lettera: 50,000 |
Nike Inc | 95.00 USD | 27/09/2024 | Call |
GlobeNewswire
10:00
Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Sub...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
07:00
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...